Snipr Biome ApS has published initial clinical data showing its Crispr-Cas modified bacteriophage product selectively kills Escherichia coli – including strains that are resistant to antibiotics – ...
The medical director at Horizon Therapeutics and the executive director at the National Kidney Foundation (NKF) of Ohio ...
Insight into the concept of biosafety materials for combating COVID-19 is presented. The advances in nanotechnology to develop diagnostics and therapeutics are highlighted. The increasing demand for ...
Meanwhile, key regulatory and pipeline updates from bigwigs like GSK GSK and Biogen BIIB were in the spotlight too during the week ... which is being developed in collaboration with Denali ...
May 31, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR ...
Here, I discuss the central investing thesis for its fellow CRISPR/Cas9 gene-editing specialist, Intellia Therapeutics (NASDAQ: NTLA). CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What ...
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CRISPR Therapeutics AG shares valued at $1,621,894 were sold by Kulkarni Samarth on May ...
Gene-editing stocks have sunk under the weight of rising interest rates and high inflation. These macroeconomic headwinds, ...
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The new release is inspired by Japanese blending traditions while aiming to "celebrate the excellence of blended Scotch ...
Suzanne Stewart Staff Writer Last week, Pocahontas County Schools Superintendent Terrence Beam announced his resignation, effective June 30. Although he was a year away from retiring from the position ...
The Sonos Beam is a great soundbar in the under $500 category, and it's even cheaper now thanks to this Best Buy deal.
Beam Therapeutics (NASDAQ: BEAM) is exactly the kind of innovative biotech business that maverick growth stock investor Cathie Wood craves. Most recently, between April 27 and May 8, Wood bought ...
Innoviz Technologies (NASDAQ:INVZ) is scheduled to announce Q1 earnings results on Wednesday, May 17th, before market open. The consensus EPS Estimate is -$0.22 (+4.3% Y/Y) and the consensus ...
By Jafer Ahmad and Abigail Kukura WASHINGTON, DC - Like electricity and artificial intelligence, biotechnology is poised to ...
JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price ...
SAB Biotherapeutics President & Chief Executive Officer Eddie Sullivan, Ph.D. to present novel DiversitAb™ platform pipeline, with emphasis on partnering influenza therapeutic, SAB-176SIOUX ...
Sensei Biotherapeutics press release (NASDAQ:SNSE): Q1 GAAP EPS of -$0.33 beats by $0.02. Cash, cash equivalents and marketable securities were $95.5 million as of March 31, 2023, as compared to $ ...
Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:01 AM. Here's what investors need to know about the announcement. Aeglea BioTherapeutics ...
Looking ahead, revenue is expected to decline by 24% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 19%. Performance of the American ...